BRIEF — Ryvu Therapeutics Signs Grant Agreement For Panacea — Novo Project With The National Center For Research And Development

Sept 18 (Reuters) — Ryvu Therapeutics SA: Signs Grant Agreement For Panacea-novo Project With The National Center For Research And Development Net Value Of Project At 133.2 Million Zlotys With Recommended Grant Value Of 105.6 Million Zlotys Planned Implementation Period For Project Is 58 Months Goal Of Panacea-novo Project Is Innovative Therapies For Treatment Of Rare Tumors Among Patients Source text:... Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;)